131 related articles for article (PubMed ID: 12642469)
1. CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids.
Nakamura H; Torimoto N; Ishii I; Ariyoshi N; Nakasa H; Ohmori S; Kitada M
Drug Metab Dispos; 2003 Apr; 31(4):432-8. PubMed ID: 12642469
[TBL] [Abstract][Full Text] [Related]
2. Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes.
Nakamura H; Nakasa H; Ishii I; Ariyoshi N; Igarashi T; Ohmori S; Kitada M
Drug Metab Dispos; 2002 May; 30(5):534-40. PubMed ID: 11950784
[TBL] [Abstract][Full Text] [Related]
3. Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells.
Ohmori S; Nakasa H; Asanome K; Kurose Y; Ishii I; Hosokawa M; Kitada M
Biochim Biophys Acta; 1998 May; 1380(3):297-304. PubMed ID: 9555064
[TBL] [Abstract][Full Text] [Related]
4. Direct interaction between substrates and endogenous steroids in the active site may change the activity of cytochrome P450 3A4.
Torimoto N; Ishii I; Hata M; Nakamura H; Imada H; Ariyoshi N; Ohmori S; Igarashi T; Kitada M
Biochemistry; 2003 Dec; 42(51):15068-77. PubMed ID: 14690416
[TBL] [Abstract][Full Text] [Related]
5. Helices F-G are important for the substrate specificities of CYP3A7.
Torimoto N; Ishii I; Toyama K; Hata M; Tanaka K; Shimomura H; Nakamura H; Ariyoshi N; Ohmori S; Kitada M
Drug Metab Dispos; 2007 Mar; 35(3):484-92. PubMed ID: 17178770
[TBL] [Abstract][Full Text] [Related]
6. Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.
Lacroix D; Sonnier M; Moncion A; Cheron G; Cresteil T
Eur J Biochem; 1997 Jul; 247(2):625-34. PubMed ID: 9266706
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Stimulatory and Inhibitory Effects of Steroid Hormones and α-Naphthoflavone on Steroid Hormone Hydroxylation Catalyzed by Human Cytochrome P450 3A Subfamilies.
Niwa T; Toyota M; Kawasaki H; Ishii R; Sasaki S
Biol Pharm Bull; 2021; 44(4):579-584. PubMed ID: 33790108
[TBL] [Abstract][Full Text] [Related]
8. CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.
Kang P; Liao M; Wester MR; Leeder JS; Pearce RE; Correia MA
Drug Metab Dispos; 2008 Mar; 36(3):490-9. PubMed ID: 18096676
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine 10,11-epoxidation in human liver microsomes: influence of the
Miyata-Nozaka Y; Zain SM; Taguchi M; Shigeyama M; Isobe T; Hanioka N
Pharmazie; 2017 Dec; 72(12):747-750. PubMed ID: 29441960
[TBL] [Abstract][Full Text] [Related]
10. Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
Williams JA; Ring BJ; Cantrell VE; Jones DR; Eckstein J; Ruterbories K; Hamman MA; Hall SD; Wrighton SA
Drug Metab Dispos; 2002 Aug; 30(8):883-91. PubMed ID: 12124305
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
Panesar SK; Bandiera SM; Abbott FS
Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine: a 'blind' assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systems.
Pelkonen O; Myllynen P; Taavitsainen P; Boobis AR; Watts P; Lake BG; Price RJ; Renwick AB; Gómez-Lechón MJ; Castell JV; Ingelman-Sundberg M; Hidestrand M; Guillouzo A; Corcos L; Goldfarb PS; Lewis DF
Xenobiotica; 2001 Jun; 31(6):321-43. PubMed ID: 11513246
[TBL] [Abstract][Full Text] [Related]
13. Steroid hydroxylation by human fetal CYP3A7 and human NADPH-cytochrome P450 reductase coexpressed in insect cells using baculovirus.
Ohmori S; Fujiki N; Nakasa H; Nakamura H; Ishii I; Itahashi K; Kitada M
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):15-28. PubMed ID: 9644715
[TBL] [Abstract][Full Text] [Related]
14. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation.
Kerr BM; Thummel KE; Wurden CJ; Klein SM; Kroetz DL; Gonzalez FJ; Levy RH
Biochem Pharmacol; 1994 Jun; 47(11):1969-79. PubMed ID: 8010982
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of carbamazepine by CYP3A6: a model for in vitro drug interactions studies.
Mesdjian E; Sérée E; Charvet B; Mirrione A; Bourgarel-Rey V; Desobry A; Barra Y
Life Sci; 1999; 64(10):827-35. PubMed ID: 10096433
[TBL] [Abstract][Full Text] [Related]
16. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.
Schuetz JD; Kauma S; Guzelian PS
J Clin Invest; 1993 Aug; 92(2):1018-24. PubMed ID: 8349787
[TBL] [Abstract][Full Text] [Related]
17. Pathways of carbamazepine bioactivation in vitro: II. The role of human cytochrome P450 enzymes in the formation of 2-hydroxyiminostilbene.
Pearce RE; Uetrecht JP; Leeder JS
Drug Metab Dispos; 2005 Dec; 33(12):1819-26. PubMed ID: 16135660
[TBL] [Abstract][Full Text] [Related]
18. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
[TBL] [Abstract][Full Text] [Related]
19. Effects of cytochrome b(5) on drug oxidation activities of human cytochrome P450 (CYP) 3As: similarity of CYP3A5 with CYP3A4 but not CYP3A7.
Yamaori S; Yamazaki H; Suzuki A; Yamada A; Tani H; Kamidate T; Fujita Ki; Kamataki T
Biochem Pharmacol; 2003 Dec; 66(12):2333-40. PubMed ID: 14637191
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro.
Granfors MT; Wang JS; Kajosaari LI; Laitila J; Neuvonen PJ; Backman JT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):79-85. PubMed ID: 16433896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]